RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

A collection of news and information related to Food and Drug Administration published by this site and its partners.

Top Food and Drug Administration Articles

Displaying items 56-66
  • U.S. Ebola patient receives experimental drug from Chimerix

    (Reuters) - After nearly a week in hospital, the first Ebola patient diagnosed in the United States began to receive an experimental therapy initially developed to treat other viral diseases, according to the Dallas hospital where he lies in critical...
  • Missouri teachers got insulin, not flu shots, lawyer says

    ST. LOUIS Two elementary school teachers in Missouri were rushed by ambulance to the hospital last month after being mistakenly dosed with insulin instead of the flu vaccine, the teachers' lawyer said Monday. Lawyer Paul Passanante said that three...
  • Novartis works with Bristol-Myers Squibb to test lung cancer drugs

    ZURICH (Reuters) - Swiss pharma group Novartis AG said on Monday it would work with Bristol-Myers Squibb Co to test the U.S. drugmaker's immuno-oncology drug Opdivo in combination with three of its own experimental lung cancer drugs. The clinical...
  • Chimerix says provides experimental Ebola drug for potential use

    (Reuters) - Drug developer Chimerix Inc said its experimental Ebola drug has been provided for potential use in patients, sending its shares up nearly 9 percent in premarket trading. The drug, brincidofovir, received Emergency Investigational New Drug...
  • Alcobra ADHD drug meets goals, after data excluded; stock tanks

    (Reuters) - Alcobra Ltd lost more than half its market value after it said its drug to treat adult attention deficit disorder met the main goals of a late-stage trial - but only after excluding data from patients who reacted positively to a placebo....
  • Sunesis slumps after cancer drug fails late-stage trial

    (Reuters) - Sunesis Pharmaceuticals Inc said its experimental cancer drug did not meet the main goal in a late-stage trial, sending the company's shares plunging 77 percent to their lowest in more than two years. The stock's slump fall wiped out over...
  • Kids exposed to BPA before birth at risk of wheeze: study

    NEW YORK (Reuters Health) - Young kids who were exposed to Bisphenol A (BPA) before birth are more likely than others to have a wheeze before age five, according to a new study that found no connection to BPA exposure after birth. Many plastic and...
  • Our national case of nerves over Ebola

    ATLANTA The sensation caused by a man traipsing through Atlanta's airport wearing a bio-containment suit this week shows how closely attuned Americans are to the Ebola epidemic and how little we seem to know about it. The spectacle at Hartsfield-...
  • Unproven Ebola cures, preventives proliferate

    Amid alarm over the Ebola virus, a flurry of pitches has sprung up for products that claim to prevent and treat the deadly infection. Online -- and increasingly on social media sites -- these products are being hawked by paid consultants, supplement gurus...
  • The latest bogus attack on Obamacare: It's anti-innovation!

    The latest bogus attack on Obamacare: It's anti-innovation!
    As the Affordable Care Act takes hold as a flag carrier for U.S. healthcare reform, assertions of its deleterious effects become more threadbare and repetitious by the day. One of the hoariest chestnuts was resurrected Wednesday in a Wall Street Journal...
  • E-cigarettes create quandry for health insurers, policymakers

    Are e-cigarettes, the popular battery-powered devices marketed as a smoking alternative, tobacco products? How government regulators, insurance companies and customers each answer that question is key to deciding whether e-cigarette users will face...